For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Sloan-Kettering Institute for Cancer Research

USPTO Granted Patents = 512

CIPO Patents = 20

EPO Patents = 65

Forward Citations = 6,227

Loading Chart...

Loading Chart...

665 inventors (with patents filed for the assignee):

Samuel J Danishefsky (76 out of 94 patents)

Lloyd J Old (32 out of 122 patents)

Ting-Chao Chou (28 out of 37 patents)

4. Philip O Livingston (28 out of 33 patents)

5. Alan N Houghton (26 out of 28 patents)

6. Nai-Kong V Cheung (21 out of 49 patents)

7. David A Scheinberg (21 out of 49 patents)

8. Paul A Marks (21 out of 27 patents)

9. Kyoichi A Watanabe (21 out of 24 patents)

10. Richard A Rifkind (19 out of 22 patents)

11. Kenneth O Lloyd (19 out of 28 patents)

12. Herbert F Oettgen (19 out of 20 patents)

13. Kenneth Allen Savin (17 out of 22 patents)

14. Gabriela Chiosis (16 out of 34 patents)

15. Ouathek Ouerfelli (16 out of 25 patents)

Core Competencies:

PI3K Inhibitors

Neurodegenerative Diseases

Ocular Prosthesis

Chimeric Receptors

Silica-Based Nanoparticles

CDC7 Kinase Inhibitors

HSP90 Inhibitors

Endothelial Cell Proliferation

Mitragynine Analogs

Glucocorticoid Inhibitors

Exosomal DNA Biomarkers

Monoclonal Antibodies

512 patents: Sort by Forward Citations

1. 12478616 - PI3K inhibitors and uses thereof (2025-11-25),

2. 12473288 - Treatment of neurodegenerative diseases through inhibiton of Hsp90 (2025-11-18),

3. 12336902 - Ocular prosthesis with display device (2025-06-24),

4. 12331129 - Chimeric receptors targeting ADGRE2 and/or CLEC12A and uses thereof (2025-06-17),

5. 12227535 - Triterpene saponins, methods of synthesis and uses thereof (2025-02-18),

6. 12221489 - Antibodies to human B7x for treatment of metastatic cancer (2025-02-11),

7. 12161734 - Multimodal silica-based nanoparticles (2024-12-10),

8. 12121525 - Methods for treating GI syndrome and graft versus host disease (2024-10-22),

9. 12109189 - CDC7 kinase inhibitors and uses thereof (2024-10-08),

10. 11913021 - Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis (2024-02-27),

11. 11760758 - Mitragynine analogs for the treatment of pain, mood disorders and substance use disorders (2023-09-19),

12. 11666550 - CDC7 kinase inhibitors and uses thereof (2023-06-06),

13. 11607465 - Uses of labeled HSP90 inhibitors (2023-03-21),

14. 11564988 - Single wall nanotube constructs and uses thereof (2023-01-31),

15. 11447515 - Triterpene saponins, methods of synthesis and uses thereof (2022-09-20),

Sloan-Kettering Institute for Cancer Research is a world-renowned cancer research institute dedicated to advancing the understanding and treatment of cancer. With a focus on innovative research, exceptional patient care, and education, the institute has made significant contributions to the field of oncology. Their website provides valuable information about the institute's research programs, clinical trials, patient care services, and educational resources.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

512 Patents

#31 in New York, NY

#56 in New York

#922 in US

#1,846 in the World

New York, NY, United States of America

Sloan-Kettering Institute for Cancer Research

Forward Citations = 6,227

665 inventors:

Samuel J Danishefsky (76 out of 94 patents)

Lloyd J Old (32 out of 122 patents)

Ting-Chao Chou (28 out of 37 patents)

4. Philip O Livingston (28 out of 33 patents)

5. Alan N Houghton (26 out of 28 patents)

Please report any incorrect information to support@idiyas.com

Loading…